CA-INVESTCLOUD
1.3.2023 14:18:01 CET | Business Wire | Press release
InvestCloud, the global leader in digital transformation for the financial industry with over $6 trillion in assets, today announced partnerships with leading asset managers, AssetCo and Westwood Group to innovate the digital distribution of financial products and strategies. Launching in the US initially, the partnership lays the foundation for both AssetCo and Westwood to tap into new markets through the InvestCloud platform’s global reach.
The partnership will see the investment strategies and financial products of AssetCo and Westwood distributed digitally via the InvestCloud Financial Supermarket (FSM)™ to financial advisors throughout the United States, starting this year. This includes the subsidiaries and associates of AssetCo—namely, River and Mercantile, SVM, Saracen, and Rize ETF.
Campbell Fleming, CEO of AssetCo, said: ”This is a time of dynamic change for AssetCo. Our partnership with InvestCloud plays a pivotal role in our transformational strategy in the US as we engage in a digital partnership to align ourselves with investors preferences of the future. We chose to partner with InvestCloud because of the quality of their digital capabilities and their global distribution. InvestCloud’s Financial Supermarket™ is a hugely innovative approach and very attractive for AssetCo and our operating companies as we support our growth strategy. InvestCloud’s digital approach to distribution will provide us with a highly efficient way for our products to reach a global audience. Through InvestCloud’s brilliant approach to data and their Digital Warehouse™, AssetCo will also attain key data insights on our strategies and our distribution across our markets, which will provide tremendous insights to serve our clients better.”
Brian Casey, CEO of Westwood Holdings Group, said: “Partnering with InvestCloud will transform the way we distribute financial products, opening up new channels and markets to reach more customers. This will help propel our growth, and in turn enable clients and advisors to more easily discover the products which best match their investment needs. We’re excited to be part of this digital revolution for financial products and portfolio construction.”
InvestCloud’s Financial Supermarket (FSM)™ will enable advisors to search for and select the best products for their clients, using industry-leading digital search capabilities and access to a multitude of virtual products, all in one digital location. The technology will also provide both AssetCo and Westwood with pace-setting data analytic capabilities to understand which products and content are resonating with specific segments.
AssetCo acquired River and Mercantile in June 2022. The partnership offers AssetCo an opportunity to quickly scale this business into the US marketplace.
Alex Hoctor-Duncan, CEO of River and Mercantile, said: “We are well aware of the potential opportunities in the US and believe our tailored strategies will be very successful through our partnership with InvestCloud. It’s an exciting new initiative, reinforcing our belief that as a dynamic boutique we can move with the times and change as the investment landscape changes. InvestCloud offers best-in-class digital distribution, with particularly powerful reach in the US, and we look forward to a very successful partnership.”
John Wise, CEO of InvestCloud, said: “We are excited to be partnering with two industry pioneers in Martin Gilbert and Brian Casey and their teams to transform the way financial products are distributed. InvestCloud has built the industry’s leading digital transformation platform with over $6 trillion in assets, and we continue to invest in innovation of the financial sector with our development of the Financial Supermarket™. These partnerships will offer tremendous distribution opportunities, with the potential to leverage over 400 wealth management firms with over 20 million investor accounts currently on InvestCloud’s global platform. We are confident that following our success together in the US, we will continue to drive growth by partnering with AssetCo in other key global markets.”
About InvestCloud
InvestCloud is a global company specializing in digital platforms that enable the development of financial solutions, pre-integrated into the cloud. The company offers on-demand client experiences and intuitive operations solutions using an ever-expanding suite of modular apps, resulting in powerful products including Communication (client portals, advisor portals, mobility and more), Planning (goal-based, cashflow, digital advice, proposals and more), Shopping & Selling (digital marketplace for financial products) and the App Library (IBOR, ABOR, performance and more). Headquartered in Los Angeles, InvestCloud has over 20 global offices including New York, London, Geneva, Singapore, Tokyo and Sydney, supporting trillions in assets across hundreds of diverse clients – from the largest banks in the world to wealth managers, asset managers and asset services companies.
InvestCloud’s clients today include over 150 asset managers, over 400 wealth managers and over 140,000 individual financial advisors. In North America alone, InvestCloud has eight of the top ten US banks and seven of the top ten US managed account sponsors.
For more information on InvestCloud, please visit www.investcloud.com
About AssetCo
AssetCo is a UK asset and wealth management business primarily involved in acquiring, managing and operating asset and wealth management activities and interests, together with other related services. The strategy principally focuses on making strategic acquisitions and building organic activities in areas of the asset and wealth management sector where structural shifts have the potential to deliver exceptional growth opportunities. This could include strategic acquisitions of undervalued asset and wealth management businesses which have core capabilities that play to these structural shifts and where active management can unlock value. Today, capabilities across the group include a listed equity businesses specialising in UK, European and Global assets, a private markets division focussed on UK Infrastructure, a sustainable thematic ETF business and a significant stake in a leading digital wealth management platform.
For more information on AssetCo, please visit www.assetco.com
About Westwood Holdings Group, Inc
Westwood Holdings Group, Inc. is a focused investment management boutique and wealth management firm. Westwood offers a broad array of investment solutions to institutional investors, private wealth clients and financial intermediaries. The firm specializes in distinct investment capabilities: U.S. Value Equity and Multi Asset, which includes Asset Allocation, Real Assets and Tactical, and are made available through separate accounts, the Westwood Funds® family of mutual funds and other pooled vehicles. Westwood benefits from significant, broad-based employee ownership and trades on the New York Stock Exchange under the symbol “WHG.” Based in Dallas, Westwood also maintains offices in Houston and San Francisco.
For more information on Westwood, please visit www.westwoodgroup.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230301005597/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom